Meet the Team
Peter Yorke, CEO: Mr. Yorke brings over 20 years of experience in the medical device industry to EndoVention. Trained as a molecular biologist and originally working at Genentech, he then entered the world of medical venture capital, first at Montgomery in San Francisco, and then as Chief Investment Officer at Art Pappas and Associates. He has been involved in several start-ups, including Sherpa Interventional Systems (sold to Stryker Instruments), and Voyomotive, for which he currently serves as CEO. He hold patents in both the medical device and automotive arena. He obtained his BA from UC Berkeley and his MBA from Anderson School at UCLA.
Shaun Samuels, MD, CMO: Dr. Samuels is an interventional radiologist who for the last 14 years has worked at the prestigious Miami Cardiac & Vascular Institute. He has now dedicated himself fully to the EndoVention project for which he has invented much of the technology. He had originally worked as a bioengineer in the research lab of Tom Fogarty at Stanford. After completing his MD at Northwestern and residency in radiology at USC, he completed a fellowship in Vascular/Interventional Radiology at Miami Vascular Institute. He returned to Stanford for 6 years as a Clinical Assistant Professor in the IR division before returning to Miami. While at MCVI, Dr. Samuels was an internationally recognized speaker, moderator and opinion leader. In addition to his daily clinical practice, he has also been a Live Case Operator at the International Symposium on Endovascular Therapy (ISET) and Trans Catheter Therapeutics (TCT). In addition, he was the driving force behind the highly successful Symposium on Clinical Interventional Oncology (CIO). He and Peter Yorke have joined together on several entrepreneurial projects, most notably on Sherpa Intervention Systems.
Shaun Samuels, MD, CMO: Dr. Samuels is an interventional radiologist who for the last 14 years has worked at the prestigious Miami Cardiac & Vascular Institute. He has now dedicated himself fully to the EndoVention project for which he has invented much of the technology. He had originally worked as a bioengineer in the research lab of Tom Fogarty at Stanford. After completing his MD at Northwestern and residency in radiology at USC, he completed a fellowship in Vascular/Interventional Radiology at Miami Vascular Institute. He returned to Stanford for 6 years as a Clinical Assistant Professor in the IR division before returning to Miami. While at MCVI, Dr. Samuels was an internationally recognized speaker, moderator and opinion leader. In addition to his daily clinical practice, he has also been a Live Case Operator at the International Symposium on Endovascular Therapy (ISET) and Trans Catheter Therapeutics (TCT). In addition, he was the driving force behind the highly successful Symposium on Clinical Interventional Oncology (CIO). He and Peter Yorke have joined together on several entrepreneurial projects, most notably on Sherpa Intervention Systems.